H. Olsen et al., REGULATION OF GLUCOSE-TRANSPORT IN THE NIH 3T3 L1 PREADIPOCYTE CELL-LINE BY TCDD, Environmental health perspectives, 102(5), 1994, pp. 454-458
This study examined the changes in cellular glucose uptake induced by
2,3,7,8 tetrachloro-dibenzo-p-dioxin (TCDD) as measured by quantificat
ion of intracellular radioactivity in the NIH 3T3 L1 preadipocyte cell
line after a 30-minute incubation with the nonmetabolizable radioacti
ve analogue of glucose, 3-O-methyl-D-[1-H-3] glucose. Treatment of dif
ferentiated NIH 3T3 L1 cells with TCDD produced a time- and dose-depen
dent decrease in the cellular uptake of glucose. Treatment of cells fo
r 3 hr with 10(-8) M TCDD significantly reduced glucose uptake to abou
t 10% of control values (p less than or equal to 0.05). Furthermore, c
ytochalasin B, a specific inhibitor of facilitative glucose transporte
r proteins totally abolished the portion of glucose transport activity
that is sensitive to TCDD. The role of the Ah receptor in TCDD-mediat
ed reduction in glucose uptake was investigated. Pretreatment of 3T3 L
1 cells with the Ah receptor blocker 4,7-phenanthroline antagonized th
e effects of TCDD on glucose uptake. Structure-activity relationship s
tudies with TCDD and two polychlorinated biphenyl (PCB) congeners reve
aled a rank order for their potency in the inhibition of glucose trans
port as follows: TCDD << 3,3',4,4' tetrachlorobiphenyl <2,2',5,5' tetr
achlorobiphenyl (TCB). Such a rank order correlates both with previous
ly determined biological activity of TCDD and the more active 3,3',4,4
' - and less active 2,2',5,5' - TCB and with affinity for binding to t
he Ah receptor. The thyroid hormone T-4, blocked the action of TCDD to
further reduce glucose uptake. Experimental evidence is consistent wi
th a proposed mechanism for TCDD to reduce the titer of functional glu
cose transporter proteins through its interaction with the Ah receptor
.